UBS Group AG - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 31 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is 3.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$13,466
+58447.8%
149,612
+59744.8%
0.00%
Q2 2023$23
-11.5%
250
+150.0%
0.00%
Q1 2023$26
+23.8%
1000.0%0.00%
Q4 2022$21100
-4.8%
0.00%
Q3 2022$01050.0%0.00%
Q2 2022$01050.0%0.00%
Q1 2022$0
-100.0%
105
-98.9%
0.00%
Q4 2021$9,0000.0%9,371
+76.9%
0.00%
Q3 2021$9,000
-25.0%
5,298
-22.2%
0.00%
Q2 2021$12,000
+140.0%
6,810
+153.5%
0.00%
Q1 2021$5,000
+150.0%
2,686
+229.2%
0.00%
Q4 2020$2,000
-60.0%
816
-54.3%
0.00%
Q3 2020$5,0001,785
+1600.0%
0.00%
Q2 2020$01050.0%0.00%
Q1 2020$0105
+2000.0%
0.00%
Q4 2019$0
-100.0%
5
-99.9%
0.00%
Q3 2019$3,0004,681
+4358.1%
0.00%
Q2 2019$01050.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2021
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders